Feuth, Eeva
Nieminen, Valtteri
Palomäki, Antti
Ranti, Juha
Sucksdorff, Marcus
Finnilä, Taru
Oksi, Jarmo
Vuorinen, Tytti
Feuth, Thijs http://orcid.org/0000-0001-6691-556X
Funding for this research was provided by:
University of Turku
Article History
Received: 10 November 2023
Accepted: 5 February 2024
First Online: 15 February 2024
Declarations
:
: According to the Finnish Medical Research Act (488/1999, Sections 1–3), non-interventional clinical studies do not require separate approval of the ethics committee. According to the Finnish legislation, including the Data Protection Act 1050/2018, the Act on the Secondary Use of Health and Social Data 552/2019, and the European Union General Data Protection Regulation 679/2016, retrospectively collected data from health registers can be used for research when permitted by the register owner without the separate approval of the ethics committee. Approval for the conduction of this study was obtained from Turku University Hospital (approval number VSSHP/2022/26334) with an exemption from informed consent as the data was anonymized. The research was conducted according to the principles of the World Medical Association Declaration of Helsinki and according to the guidelines of Good Clinical Practice.
: EF, VN, JR, MS, TaF, and TV declare they have no financial interests. AP has received speaker honoraria from Boehringer-Ingelheim, Pfizer, and Abbvie, and travel support for participation in conferences from Abbvie and Novartis. JO has received speaker honoraria from Advanz Pharma, Biocodex, GlaxoSmithKline, MSD Finland, Pfizer, Roche, and Tillotts, and travel support for participation in conferences from Gilead and Unimedic Pharma. ThF has received speaker honoraria from GSK and Pfizer, consultant honorarium from BioMérieux, and travel support for participation in conferences from AstraZeneca and GSK. Non-financial interests: AP has served on advisory boards for AbbVie and Amgen. JO has served on review panel or advisory committee for GlaxoSmithKline, MSD Finland, Pfizer, and AstraZeneca.